CLB - Core Laboratories N.V.
NYSE
->
Energy
->
Oil & Gas Equipment & Services
Amstelveen,
Netherlands
Type: Equity
CLB price evolution
CLB
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $15.12 | $16.62 | $26.2 | $16.29 |
| Short term investments | ||||
| Net receivables | $109.35 | $104.05 | $106.82 | $110.7 |
| Inventory | $71.7 | $75.06 | $71.66 | $67.34 |
| Total current assets | $222.97 | $228.54 | $236.12 | $227.93 |
| Long term investments | ||||
| Property, plant & equipment | $153.47 | $152.6 | $157.12 | $159 |
| Goodwill & intangible assets | $106.37 | $106.72 | $106.86 | $106.71 |
| Total noncurrent assets | $363.26 | $363.87 | $365.72 | $365.69 |
| Total investments | ||||
| Total assets | $592.6 | $592.41 | $601.85 | $593.62 |
| Current liabilities | ||||
| Accounts payable | $33.51 | $34.1 | $39.15 | $38.37 |
| Deferred revenue | $4.75 | $4.64 | $5.54 | $5.95 |
| Short long term debt | $10.18 | $9.79 | $10.73 | $11.07 |
| Total current liabilities | $87.47 | $84.25 | $96.19 | $95.62 |
| Long term debt | $163.13 | $218.77 | $224.96 | $224.23 |
| Total noncurrent liabilities | $268.49 | $278.71 | $286.05 | $297.84 |
| Total debt | $215.38 | $228.56 | $235.69 | $235.31 |
| Total liabilities | $358.53 | $362.96 | $382.24 | $393.47 |
| Shareholders' equity | ||||
| Retained earnings | $120.76 | $119.02 | $110.23 | $87.86 |
| Other shareholder equity | $234.07 | -$3.84 | -$3.54 | -$3.54 |
| Total shareholder equity | $224.81 | $224.69 | $214.76 | $195.39 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $15.12 | $15.43 | $17.7 | $13.81 |
| Short term investments | ||||
| Net receivables | $109.35 | $106.91 | $96.83 | $83.19 |
| Inventory | $71.7 | $60.45 | $45.44 | $38.15 |
| Total current assets | $222.97 | $211.7 | $189.06 | $165.85 |
| Long term investments | ||||
| Property, plant & equipment | $153.47 | $157.41 | $172.34 | $181.68 |
| Goodwill & intangible assets | $106.37 | $106.93 | $107.58 | $108.03 |
| Total noncurrent assets | $363.26 | $366.65 | $391.8 | $402.73 |
| Total investments | ||||
| Total assets | $592.6 | $578.35 | $580.85 | $568.58 |
| Current liabilities | ||||
| Accounts payable | $33.51 | $45.85 | $29.73 | $23.03 |
| Deferred revenue | $4.75 | $5.94 | $7.76 | $5.46 |
| Short long term debt | $10.18 | $11.7 | $12.34 | $11.44 |
| Total current liabilities | $87.47 | $103.14 | $90.78 | $89.75 |
| Long term debt | $163.13 | $172.39 | $237.92 | $315.54 |
| Total noncurrent liabilities | $268.49 | $286.26 | $329.07 | $403.26 |
| Total debt | $215.38 | $222.39 | $250.26 | $326.98 |
| Total liabilities | $358.53 | $389.4 | $419.85 | $493.01 |
| Shareholders' equity | ||||
| Retained earnings | $120.76 | $85.95 | $68.35 | $50.46 |
| Other shareholder equity | $234.07 | $188.95 | -$10.13 | -$7.2 |
| Total shareholder equity | $224.81 | $184.26 | $156.45 | $71.51 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $128.21 | $125.34 | $127.88 | $128.36 |
| Cost of revenue | $96.62 | $100.3 | $101.53 | |
| Gross Profit | $26.69 | $28.73 | $27.59 | $26.83 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $9.45 | $5.81 | $16.33 | |
| Total operating expenses | $12.11 | $14.05 | $8.68 | $20.35 |
| Operating income | $14.67 | $18.91 | $6.48 | |
| Income from continuing operations | ||||
| EBIT | $14.71 | $18.82 | $6.41 | |
| Income tax expense | $4.26 | $2.31 | -$7.26 | $0.61 |
| Interest expense | -$3.62 | $3.15 | $3.24 | $3.43 |
| Net income | ||||
| Net income | $6.46 | $9.26 | $22.85 | $2.37 |
| Income (for common shares) | $9.26 | $22.85 | $2.37 | |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $489.74 | $487.27 | ||
| Cost of revenue | $393.65 | $374.77 | ||
| Gross Profit | $96.08 | $112.5 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $38.12 | $34.03 | ||
| Total operating expenses | $54.56 | $189.31 | ||
| Operating income | $41.52 | -$76.81 | ||
| Income from continuing operations | ||||
| EBIT | $41.32 | -$77.37 | ||
| Income tax expense | $10.3 | $5.9 | ||
| Interest expense | $11.57 | $14.37 | ||
| Net income | ||||
| Net income | $19.45 | -$97.64 | ||
| Income (for common shares) | $19.45 | -$97.64 | ||
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $9.26 | $22.85 | $2.37 | |
| Operating activities | ||||
| Depreciation | $3.93 | $3.94 | $4.04 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.07 | $1.35 | $8.98 | |
| Total cash flows from operations | -$0.21 | $8.74 | -$3.17 | |
| Investing activities | ||||
| Capital expenditures | -$3.39 | -$2.15 | -$2.04 | |
| Investments | ||||
| Total cash flows from investing | -$6.65 | -$3.39 | $1.22 | -$2.04 |
| Financing activities | ||||
| Dividends paid | -$1.87 | -$0.47 | -$0.47 | -$0.47 |
| Sale and purchase of stock | -$0.22 | -$0.2 | -$0 | |
| Net borrowings | -$5.25 | $2 | $8 | |
| Total cash flows from financing | -$18.45 | -$5.99 | -$0.04 | $6.06 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$0.31 | -$9.59 | $9.92 | $0.86 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $19.45 | $19.73 | -$97.64 | |
| Operating activities | ||||
| Depreciation | $17.16 | $18.52 | $20.87 | |
| Business acquisitions & disposals | $0.24 | $0.87 | -$0.23 | |
| Stock-based compensation | $7.76 | $19.09 | $7.39 | |
| Total cash flows from operations | $24.96 | $36.58 | $57.87 | |
| Investing activities | ||||
| Capital expenditures | -$8.36 | -$13.18 | -$10.64 | |
| Investments | ||||
| Total cash flows from investing | -$6.65 | -$3.86 | -$10.22 | $7.85 |
| Financing activities | ||||
| Dividends paid | -$1.87 | -$1.85 | -$1.83 | -$12.45 |
| Sale and purchase of stock | -$3.9 | $51.74 | -$2.79 | |
| Net borrowings | -$17.21 | -$71 | -$46 | |
| Total cash flows from financing | -$18.45 | -$23.38 | -$22.46 | -$63.01 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$0.31 | -$2.27 | $3.9 | $2.71 |
News
Fundamentals
| Market cap | $772.34M |
|---|---|
| Enterprise value | $972.61M |
| Shares outstanding | 46.72M |
| Revenue | $509.79M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $40.94M |
| Revenue Q/Q | 0.50% |
| Revenue Y/Y | 4.10% |
| P/E ratio | 18.87 |
|---|---|
| EV/Sales | 1.91 |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.52 |
| P/B ratio | -83.44 |
| Book/Share | -0.20 |
| Cash/Share | 0.32 |
| EPS | $0.88 |
|---|---|
| ROA | 6.88% |
| ROE | 19.05% |
| Debt/Equity | 1.59 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.55 |
| Quick ratio | 1.73 |